1. Home
  2. MRK vs FCNCP Comparison

MRK vs FCNCP Comparison

Compare MRK & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRK
  • FCNCP
  • Stock Information
  • Founded
  • MRK 2000
  • FCNCP N/A
  • Country
  • MRK United States
  • FCNCP United States
  • Employees
  • MRK N/A
  • FCNCP 17475
  • Industry
  • MRK Biotechnology: Pharmaceutical Preparations
  • FCNCP Major Banks
  • Sector
  • MRK Health Care
  • FCNCP Finance
  • Exchange
  • MRK Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • MRK 218.8B
  • FCNCP N/A
  • IPO Year
  • MRK N/A
  • FCNCP N/A
  • Fundamental
  • Price
  • MRK $82.67
  • FCNCP $22.30
  • Analyst Decision
  • MRK Buy
  • FCNCP
  • Analyst Count
  • MRK 15
  • FCNCP 0
  • Target Price
  • MRK $105.29
  • FCNCP N/A
  • AVG Volume (30 Days)
  • MRK 10.2M
  • FCNCP N/A
  • Earning Date
  • MRK 10-30-2025
  • FCNCP N/A
  • Dividend Yield
  • MRK 3.93%
  • FCNCP N/A
  • EPS Growth
  • MRK 58.06
  • FCNCP N/A
  • EPS
  • MRK 7.56
  • FCNCP N/A
  • Revenue
  • MRK $64,235,000,000.00
  • FCNCP N/A
  • Revenue This Year
  • MRK $1.82
  • FCNCP N/A
  • Revenue Next Year
  • MRK $5.10
  • FCNCP N/A
  • P/E Ratio
  • MRK $10.92
  • FCNCP N/A
  • Revenue Growth
  • MRK 1.68
  • FCNCP N/A
  • 52 Week Low
  • MRK $73.31
  • FCNCP N/A
  • 52 Week High
  • MRK $105.07
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • MRK 38.95
  • FCNCP 51.33
  • Support Level
  • MRK $83.30
  • FCNCP $22.22
  • Resistance Level
  • MRK $88.30
  • FCNCP $22.55
  • Average True Range (ATR)
  • MRK 1.83
  • FCNCP 0.20
  • MACD
  • MRK -0.40
  • FCNCP -0.01
  • Stochastic Oscillator
  • MRK 5.12
  • FCNCP 49.99

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: